- Shares of Horizon Pharma (HZNP +9.4%) are moving sharply to the upside in afternoon trading.
- The stock may be getting a boost from a positive mention on Jim Cramer's Mad Money Wednesday evening.
- Cramer called HZNP "a good spec."
- With today's gains, the shares are up some 55% this month, helped tremendously by a well received deal to acquire the rights to Vimovo.
From other sites
at 4-traders.com (Mon, 7:00AM)
at Zacks.com (Mar 4, 2015)
at Zacks.com (Mar 2, 2015)
at Investor's Business Daily (Feb 27, 2015)
at Nasdaq.com (Jan 29, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs